R&D
TRHC’s MedWise Risk Score™ Reduces the Odds of Adverse Drug Events, Keeping Patients Safer
TRHC Fills the Information Gap on COVID-19 Proposed Therapies with a New Digital Resource
TRHC Launches First Large Simulation Study to Assess Adverse Drug Events with proposed COVID-19 Treatments
TRHC Chief Scientific Officer Featured in Today’s Geriatric Medicine
Talk To Your Pharmacist Podcast Featuring Jenny Bingham, PharmD, BCACP